Trade Mark Journal No.2025/021 23 May 2025
WO0000001852642 (5,35,42,44)
Office of origin: United States of America
Date of International Registration:20 March 2025
Date of designation in the UK:
20 March 2025
The mark consists of the stylized wording "CURADEL PHARMA", to the left of which is a shaded circle surrounded by two curved lines extending in opposite directions.
Registration of this mark shall give no rights to the exclusive use of "PHARMA"
- Class 5
- Contrast agents for use in surgical and medical imaging and visualization; fluorescent contrast agents for use in surgical and medical imaging and visualization; exogenous contrast agents for use in surgical and medical imaging and visualization; near-infrared contrast agents for use in surgical and medical imaging and visualization; exogenous near-infrared contrast agents for use in surgical and medical imaging and visualization; near-infrared contrast agents for use in surgical procedures; exogenous near-infrared contrast agents for use in surgical procedures; near-infrared contrast agents for use in medical imaging and visualization; exogenous near-infrared contrast agents for use in medical imaging and visualization; near-infrared contrast agents for use in real-time surgical imaging and visualization; exogenous near-infrared contrast agents for use in real-time surgical imaging and visualization; none of the foregoing being ophthalmic preparations, otorhinolaryngological preparations, or preparations for the treatment of inflammation.
- Class 35
- Providing consumer information in the field of cancer treatment and diagnosis via the Internet and social media.
- Class 42
- Medical and scientific research services in the field of cancer treatment and diagnosis.
- Class 44
- Providing health information in the field of cancer treatment and diagnosis via the Internet and social media.
Curadel Surgical Innovations, Inc.
Representative: Gregory N. Brescia Gordon & Rees LLP, 500 Mamaroneck Ave, Suite 503, Harrison NY 10528, UNITED STATES OF AMERICA